-
1.HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS 有权
Title translation: 羟甲基吡咯烷作为β3肾上腺素能受体激动剂公开(公告)号:EP2276756B8
公开(公告)日:2012-04-11
申请号:EP09726601.9
申请日:2009-04-02
Applicant: Merck Sharp & Dohme Corp.
Inventor: BERGER, Richard , CHANG, Lehua , EDMONDSON, Scott, D. , GOBLE, Stephen, D. , HA, Sookhee, Nicole , KAR, Nam, Fung , KOPKA, Ihor, E. , LI, Bing , MORRIELLO, Gregori, J. , MOYES, Chris, R. , SHEN, Dong-Ming , WANG, Liping , ZHU, Cheng
IPC: C07D401/12 , C07D403/12 , C07D417/12 , C07D471/04 , C07D487/04 , A61P13/00 , A61K31/4178 , A61K31/506
CPC classification number: C07D487/04 , C07D401/12 , C07D403/12 , C07D417/12 , C07D471/04
-
2.HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS 有权
Title translation: 羟甲基吡咯烷作为β3肾上腺素能受体激动剂公开(公告)号:EP2276756A1
公开(公告)日:2011-01-26
申请号:EP09726601.9
申请日:2009-04-02
Applicant: Merck Sharp & Dohme Corp.
Inventor: BERGER, Richard , CHANG, Lehua , EDMONDSON, Scott, D. , GOBLE, Stephen, D. , HA, Sookhee, Nicole , KAR, Nam, Fung , KOPKA, Ihor, E. , LI, Bing , MORRIELLO, Gregori, J. , MOYES, Chris, R. , SHEN, Dong-Ming , WANG, Liping , ZHU, Cheng
IPC: C07D401/12 , C07D403/12 , C07D417/12 , C07D471/04 , C07D487/04 , A61P13/00 , A61K31/4178 , A61K31/506
CPC classification number: C07D487/04 , C07D401/12 , C07D403/12 , C07D417/12 , C07D471/04
Abstract: The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Abstract translation: 本发明提供式(I)的化合物,其药物组合物及其在治疗或预防由β3-肾上腺素受体激活介导的疾病中的使用方法。
-
公开(公告)号:EP2274296B1
公开(公告)日:2012-10-17
申请号:EP09726940.1
申请日:2009-03-23
Applicant: Merck Sharp & Dohme Corp.
Inventor: BERGER, Richard , CHANG, Lehua , EDMONDSON, Scott, D. , GOBLE, Stephen, D. , HARPER, Bart , KAR, Nam, Fung , KOPKA, Ihor, E. , LI, Bing , MORRIELLO, Gregori, J. , MOYES, Chris, R. , SHEN, Dong-ming , WANG, Liping , WENDT, Harvey , ZHU, Cheng
IPC: C07D401/06 , C07D401/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04 , A61K31/4406 , A61P13/10
CPC classification number: C07D417/14 , C07D401/06 , C07D401/14 , C07D405/14 , C07D413/14 , C07D487/04 , C07D495/04
-
4.HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS 有权
Title translation: 羟甲基吡咯烷作为β3肾上腺素能受体激动剂公开(公告)号:EP2274296A1
公开(公告)日:2011-01-19
申请号:EP09726940.1
申请日:2009-03-23
Applicant: Merck Sharp & Dohme Corp.
Inventor: BERGER, Richard , CHANG, Lehua , EDMONDSON, Scott, D. , GOBLE, Stephen, D. , HARPER, Bart , KAR, Nam, Fung , KOPKA, Ihor, E. , LI, Bing , MORRIELLO, Gregori, J. , MOYES, Chris, R. , SHEN, Dong-ming , WANG, Liping , WENDT, Harvey , ZHU, Cheng
IPC: C07D401/06 , C07D401/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04 , A61K31/4406 , A61P13/10
CPC classification number: C07D417/14 , C07D401/06 , C07D401/14 , C07D405/14 , C07D413/14 , C07D487/04 , C07D495/04
Abstract: The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Abstract translation: 本发明提供了式I化合物,其药物组合物及其在治疗或预防由β3-肾上腺素受体激活介导的疾病中的使用方法。
-
5.HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS 有权
Title translation: 羟甲基吡咯烷,β-3肾上腺素能受体激动剂公开(公告)号:EP2276756B9
公开(公告)日:2012-08-15
申请号:EP09726601.9
申请日:2009-04-02
Applicant: Merck Sharp & Dohme Corp.
Inventor: BERGER, Richard , CHANG, Lehua , EDMONDSON, Scott, D. , GOBLE, Stephen, D. , HA, Sookhee, Nicole , KAR, Nam, Fung , KOPKA, Ihor, E. , LI, Bing , MORRIELLO, Gregori, J. , MOYES, Chris, R. , SHEN, Dong-Ming , WANG, Liping , ZHU, Cheng
IPC: C07D401/12 , C07D403/12 , C07D417/12 , C07D471/04 , C07D487/04 , A61P13/00 , A61K31/4178 , A61K31/506
CPC classification number: C07D487/04 , C07D401/12 , C07D403/12 , C07D417/12 , C07D471/04
Abstract: The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
-
6.HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS 有权
Title translation: 羟基甲基ALSβ3肾上腺素能REZEPTORAGONISTEN公开(公告)号:EP2276756B1
公开(公告)日:2011-11-30
申请号:EP09726601.9
申请日:2009-04-02
Applicant: Merck Sharp & Dohme Corp.
Inventor: BERGER, Richard , CHANG, Lehua , EDMONDSON, Scott, D. , GOBLE, Stephen, D. , HA, Sookhee, Nicole , KAR, Nam, Fung , KOPKA, Ihor, E. , LI, Bing , MORRIELLO, Gregori, J. , MOYES, Chris, R. , SHEN, Dong-Ming , WANG, Liping , ZHU, Cheng
IPC: C07D401/12 , C07D403/12 , C07D417/12 , C07D471/04 , C07D487/04 , A61P13/00 , A61K31/4178 , A61K31/506
CPC classification number: C07D487/04 , C07D401/12 , C07D403/12 , C07D417/12 , C07D471/04
Abstract: The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
-
-
-
-
-